ArticleRelease.health

Tablets

TCL 341 White Pill: Identification, Drug Class, and Safety Notes

Quick identification The TCL 341 white pill is commonly identified in U.S. pill-reference listings as cetirizine hydrochloride 10 mg , an oral…

By Dr. Amina Rahman, PharmD10 min read

Reviewed by Medical Review Team ·

TCL 341 White Pill: Identification, Drug Class, and Safety Notes

Quick identification

The TCL 341 white pill is commonly identified in U.S. pill-reference listings as cetirizine hydrochloride 10 mg, an oral antihistamine used for allergy symptoms. However, an imprint is a clue—not proof of identity. Do not take a loose or unfamiliar pill based on its color or a web search. Check both sides, the dosage form, packaging, and country of origin, then confirm it with a pharmacist or a reliable official pill-identification resource. The keyword category may say “capsule,” but TCL 341 is generally described as a tablet, not a capsule; confirm the actual dosage form on the product in hand. [verify: current manufacturer and official pill-identification listing for TCL 341]

Definition and classification

If the identification is confirmed, the active ingredient is cetirizine hydrochloride, a second-generation H1 antihistamine. “Second-generation” describes a class of antihistamines generally associated with less central nervous system penetration than older first-generation agents, although cetirizine can still cause sleepiness in some people.

An imprint such as “TCL 341” is a manufacturer or product identifier used to help distinguish a tablet. It does not state the drug’s intended use, establish that the tablet is genuine, or guarantee that a pill with a similar appearance contains the same ingredient. Tablet color and shape can vary between manufacturers and markets. The product label and a verified identification are more useful than appearance alone.

Classification, if confirmed:

  • Generic name: cetirizine hydrochloride
  • Drug class: second-generation H1-receptor antihistamine
  • Dosage form associated with this imprint: commonly listed as a tablet; confirm the physical product
  • Common therapeutic role: relief of allergic symptoms, as directed by the product label or a clinician

Brand names and generic products can contain the same active ingredient, but brand, manufacturer, tablet appearance, and inactive ingredients may differ. Do not treat two products as interchangeable unless their active ingredients, strength, route, and formulation match. A tablet is not automatically interchangeable with a capsule or liquid formulation.

Mechanism of action

Histamine is a signaling chemical involved in allergy symptoms. When histamine activates H1 receptors in tissues, it can contribute to symptoms such as sneezing, itching, watery eyes, and a runny nose. Cetirizine acts mainly as a peripheral H1-receptor antagonist or inverse agonist, reducing the effects of histamine at these receptors. This can ease certain allergy symptoms, but it does not remove the underlying allergen or treat every cause of nasal or skin symptoms.

The mechanism is useful for exams because it connects the drug class to its expected effect: H1 blockade reduces histamine-mediated symptoms. It also helps explain why cetirizine is not a substitute for emergency treatment of a severe allergic reaction. Anyone with possible anaphylaxis needs urgent emergency care; an oral antihistamine should not delay emergency treatment.

Clinical significance and counseling

Cetirizine products are used for allergy-related symptoms, subject to the product’s approved labeling and individual clinical circumstances. The exact indication and directions depend on the specific product and jurisdiction. Do not infer a dosing schedule from an imprint, an identification result, or a different package. Follow the label or the instructions provided by the prescribing clinician, and ask a pharmacist if the product or directions are unclear.

Practical counseling points include:

  • Confirm the active ingredient and strength. Look for “cetirizine hydrochloride” and the strength on the original package. Do not rely on a loose tablet’s color.
  • Check the formulation and route. A tablet, capsule, chewable product, and liquid may have different instructions. Do not assume they can be substituted unit for unit.
  • Consider drowsiness. Cetirizine can cause sleepiness or reduced alertness. Until a person knows how it affects them, use caution with driving, cycling in traffic, operating machinery, or other tasks requiring alertness. Alcohol and other sedating substances may add to impairment.
  • Avoid unintended duplicate ingredients. Some combination allergy, cold, or nighttime products may contain an antihistamine. Read every active-ingredient panel and ask a pharmacist about overlapping products.
  • Use extra care when medical factors apply. Age, pregnancy or breastfeeding, kidney problems, other medicines, and a history of medication reactions can affect whether a product is suitable. Seek individualized advice rather than relying on a general pill-identification page.
  • Do not use someone else’s medicine. A tablet identified as cetirizine may still be unsuitable for another person, and a misidentified pill may contain a different drug.

A pharmacist or clinician can help check whether the product matches the intended medicine, review possible interactions, and explain the correct label directions. This is especially important when the pill is loose, the package is missing, the person takes multiple medicines, or the product is for a child.

Adverse effects and warning signs

Commonly reported effects of cetirizine can include sleepiness, fatigue, dry mouth, and dizziness. The likelihood and severity vary. Consult the product information for the specific formulation and discuss persistent or troublesome effects with a healthcare professional. Do not drive or perform hazardous tasks if impaired.

Get urgent medical help for signs of a severe allergic reaction or another serious emergency, such as difficulty breathing, swelling of the face or throat, fainting, or rapidly worsening symptoms. If a person has taken an unknown pill, a larger amount than directed, or a product not intended for them, contact a poison center or local urgent medical service for advice. If the person is unconscious, having seizures, or struggling to breathe, call local emergency services immediately. Keep the packaging or remaining pill available for responders, but do not delay urgent care to identify it.

For a suspected medication error or poisoning in the United States, Poison Control can be reached at 1-800-222-1222; elsewhere, use the local poison center or emergency service. [verify: current poison-center contact information for the reader’s location]

Identification checklist for a loose TCL 341 pill

Before treating an imprint match as reliable, check the following:

  1. Imprint on both sides: Confirm that the characters are exactly “TCL 341,” including their order. Worn, smudged, or partially visible lettering can be misread.
  2. Shape and dosage form: Note whether it is round, oval, or another shape, and whether it is a tablet or capsule. The product descriptions associated with an imprint should match the object in hand.
  3. Color and scoring: White color alone is not distinctive. Check whether a score line is present, but do not use it to infer a dose or whether splitting is appropriate.
  4. Packaging and source: Original, intact packaging with a readable ingredient panel is generally more informative than a loose pill. Be cautious with medicines from unverified sellers or containers without labels.
  5. Professional confirmation: Show the pill and any packaging to a pharmacist. If the imprint, shape, packaging, or country of origin does not match, do not assume the identification is correct.

Pill-identification databases can help narrow possibilities, but they cannot authenticate an individual pill or rule out counterfeiting, contamination, or a dispensing error. If there is any uncertainty, avoid taking the loose tablet until it has been checked by a qualified professional.

Pharm-D study notes

Classification and pharmacology

For revision, place cetirizine in the second-generation H1-antihistamine group. Its main pharmacologic action is reducing histamine activity at peripheral H1 receptors. The clinically relevant teaching point is not that it is “non-sedating,” but that sedation is generally less prominent than with many first-generation antihistamines and can still occur. Individual response, concurrent sedatives, and the task being performed matter in counseling.

The imprint itself is not a pharmacologic classification. “TCL 341” identifies a reported product presentation; it is not an ingredient name, a dose instruction, or a therapeutic indication. Always separate the identification question (“What might this pill be?”) from the pharmacology question (“What does confirmed cetirizine do?”). For another drug-specific Pharm-D review, see What Is Zofran? Uses, Mechanism and Pharm-D Safety Notes.

Clinical significance

Cetirizine is relevant to symptomatic management of allergic conditions, but symptoms such as sneezing, itching, or a runny nose are not specific to allergy. Infection, irritants, and other conditions can produce overlapping symptoms. A pill-identification article cannot establish the cause of a person’s symptoms or determine whether an antihistamine is appropriate.

Counseling should account for sedation and additive impairment, duplicate antihistamine exposure, age, organ function, pregnancy or breastfeeding, and the patient’s full medication list. The exact product label remains central because formulations and approved directions vary. For an acute severe allergic reaction, oral antihistamine use must not delay emergency assessment and treatment.

High-yield exam points

  • Drug class: second-generation H1 antihistamine, if the pill identity is confirmed.
  • Mechanism: reduces histamine-mediated effects through peripheral H1-receptor antagonism/inverse agonism.
  • Expected role: symptom relief for certain allergic symptoms; it is not an allergen-removing treatment or a replacement for emergency management of anaphylaxis.
  • Safety counseling: possible drowsiness; consider alcohol and other sedating substances, and caution against hazardous activities if impaired.
  • Medication-use review: check for duplicate antihistamines in combination products and confirm the active ingredient and strength.
  • Identification principle: imprint, shape, color, formulation, packaging, and jurisdiction should agree; no single visual feature proves identity.
  • Communication point: report the generic ingredient separately from a brand name and do not treat different salts, strengths, or dosage forms as automatically interchangeable.

Common confusions

“It is white, so it must be cetirizine.” No. Many unrelated medicines are white. Color has low identifying value without a matching imprint, shape, product record, and packaging.

“TCL 341 is a capsule.” The category label or search term may say capsule, but this imprint is commonly described as a tablet. Inspect the physical dosage form and verify it against the product information instead of accepting a category label as proof.

“Second-generation means it cannot cause sleepiness.” No. Cetirizine can cause drowsiness or impaired alertness in some people. Counseling should use accurate, qualified language rather than promising that sedation will not occur.

“A pill identifier can confirm my tablet is genuine.” No. An identifier compares reported features with a database; it cannot authenticate a specific pill, verify its contents, or confirm that it was dispensed correctly.

“All allergy medicines are interchangeable.” No. Allergy products can contain different active ingredients, strengths, combinations, and dosage forms. Compare the full label and ask a pharmacist before substituting.

FAQ

Can I take a loose TCL 341 pill I found?

Do not take an unidentified loose pill. The imprint is commonly associated with cetirizine hydrochloride 10 mg, but that association does not confirm the contents of the individual tablet. Have a pharmacist check it or use the original labeled packaging. If someone has already taken an unknown pill, seek poison-center or medical guidance.

Does TCL 341 identify the dose by itself?

It is commonly listed in connection with cetirizine hydrochloride 10 mg, but an imprint should not be used as the sole basis for deciding what was taken or how to take it. Confirm the active ingredient and strength from the original label or a pharmacist. Follow the directions for the exact product rather than inferring a schedule from an listing.

Can cetirizine make someone sleepy?

Yes. Sleepiness, fatigue, or dizziness may occur, even though cetirizine is classified as a second-generation antihistamine. Avoid hazardous activities if alertness is affected, and ask a pharmacist about alcohol or other medicines that may increase sedation.

What should I do if the pill looks different from the listing?

Do not assume the difference is harmless. Imprints can be misread and product appearances can vary, but a mismatch in imprint, shape, or dosage form needs confirmation. Keep the pill and its packaging separate from other medicines and ask a pharmacist to identify it.

Medical disclaimer

This article is for health education and Pharm-D revision, not personal medical advice or a substitute for a product label, pharmacist, or clinician. Pill-identification information can be incomplete or vary by manufacturer and country. Do not take an unfamiliar or loose medicine based on an match. For an accidental ingestion, a possible overdose, a serious reaction, or breathing difficulty, contact a poison center or emergency services as appropriate.



Related reading

Explore practical guidance on another medicine’s uses, dosing, and safety.

Important Medical Disclaimer

This article is for general educational purposes and is not a substitute for advice from a qualified doctor or pharmacist. Always consult your doctor/pharmacist before using any medicine, changing a dose, or starting treatment.

Keep reading

Related articles

Tablets

Rigix Tablet Uses: Allergy Relief, Dose and Safety

Learn what Rigix treats, how to check its cetirizine strength, and when sleepiness, kidney problems or persistent itching need a pharmacist’s advice.

Dr. Amina Rahman, PharmD13 min

Tablets

Nims Tablet Uses: Pain Relief, Dose and Liver Safety

Learn what Nims tablets may treat, how to check the ingredient, and when to stop. Practical guidance on dosing, liver risks and safer pain relief.

Dr. Amina Rahman, PharmD12 min

Pharmacognosy

What Is Zofran? Uses, Mechanism and Pharm-D Safety Notes

Understand ondansetron’s mechanism, approved uses, dosing principles and QT risks, with practical counseling and high-yield Pharm-D revision notes.

Dr. Amina Rahman, PharmD12 min

Tablets

Ascard Tablet Overview: Uses, Dosage and Safe Use Tips

Understand what Ascard contains, why doctors prescribe it, and how to avoid bleeding risks, missed-dose mistakes and unsafe tablet substitutions.

Dr. Amina Rahman, PharmD13 min

Tablets

Celbex Tablet Uses: Check the Ingredient and Use Safely

Check Celbex’s active ingredient before use, then learn about celecoxib pain relief, stomach and heart risks, interactions, and when to seek urgent help.

Dr. Amina Rahman, PharmD13 min

Tablets

Deltacortril Tablet Uses: Benefits, Risks and Safe Use

Learn why prednisolone is prescribed, which Deltacortril label details to check, and when side effects or stopping treatment need medical advice.

Dr. Amina Rahman, PharmD13 min